Innate Pharma S.A. (IPHA)
NASDAQ: IPHA
· Real-Time Price · USD
2.17
0.03 (1.40%)
At close: Oct 17, 2025, 12:06 PM
Innate Pharma S.A. Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 12.62M | 51.9M | 57.67M | 12.11M |
Cost of Revenue | 51.98M | 56.02M | 51.66M | 47M |
Gross Profit | 12.62M | 5.62M | 6.01M | -22.3M |
Operating Income | -51.58M | -12.67M | -57.42M | -47.83M |
Interest Income | 2.44M | 3.18M | 546K | 327K |
Pretax Income | -49.47M | -7.57M | -57.97M | -45.48M |
Net Income | -49.47M | -7.57M | -58.1M | -52.81M |
Selling & General & Admin | 11.93M | 11.75M | 14.47M | 25.52M |
Research & Development | 51.98M | 56.02M | 51.66M | 47M |
Other Expenses | 283K | -49.48M | -2.7M | -47M |
Operating Expenses | 64.2M | 18.29M | 63.44M | 25.52M |
Interest Expense | 566K | 640K | 288K | 312K |
Selling & Marketing Expenses | n/a | n/a | 530K | 9.53M |
Cost & Expenses | 64.2M | 74.31M | 115.1M | 59.94M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 81.05M | 84.11M | 79.59M | 79.54M |
Shares Outstanding (Diluted) | 81.05M | 84.11M | 79.64M | 79.54M |
EPS (Basic) | -0.61 | -0.09 | -0.73 | -0.57 |
EPS (Diluted) | -0.61 | -0.09 | -0.73 | -0.57 |
EBITDA | -46.91M | -1.84M | -12.28M | -43.23M |
EBIT | -48.91M | -6.93M | -57.68M | -47.83M |
Depreciation & Amortization | 1.99M | 5.09M | 45.41M | 4.6M |
Source: Financial Modeling Prep. Financial Sources.